Skip to Main Content

Paper Details

ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation.
J Clin Invest
125
2018
Author NameAffiliation
Thomas P ConradsInova Schar Cancer Institute, Inova Center for Personalized Health
Phuoc T TranJohns Hopkins University
Christopher J BakkenistUniversity of Pittsburgh School of Medicine
Christopher J BakkenistUniversity of Pittsburgh School of Medicine
  • 1 - 4

Datasets

Release 1.2